LINOZEM® Injection

LINOZEM® contains Linezolid 600mg in 300ml solution for IV use. Linezolid is a synthetic oxazolidinone antibiotic effective against a broad range of multi-drug resistant (MDR) Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococci).

Description

Composition (Per 300ml Vial):

  • Linezolid IP – 600 mg
    Form: Ready-to-use sterile IV infusion
    Route of Administration: Intravenous (slow infusion)
    Pack Size: 300 ml bottle (single dose)
    Category: Oxazolidinone Antibiotic | Hospital Antibiotic | Gram-Positive Coverage


Product Description:

LINOZEM® contains Linezolid 600mg in 300ml solution for IV use. Linezolid is a synthetic oxazolidinone antibiotic effective against a broad range of multi-drug resistant (MDR) Gram-positive bacteria, including MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococci).

LINOZEM® is ideal for hospitalized patients with confirmed or suspected resistant infections where oral therapy is not appropriate or effective.


Key Benefits:

  • Excellent efficacy against resistant Gram-positive organisms

  • Suitable for nosocomial pneumonia, skin and soft tissue infections, bone infections, and bacteremia

  • Reliable alternative when vancomycin or teicoplanin resistance is suspected

  • Ready-to-use IV infusion, eliminating dilution or compounding steps


How It Works:

Linezolid inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit, preventing the formation of the functional 70S initiation complex, which is essential for bacterial reproduction.

This unique mechanism reduces cross-resistance and makes it effective against drug-resistant pathogens.


How to Use:

  • Administer intravenously over 30 to 120 minutes using standard infusion protocols

  • Usual adult dose: 600 mg twice daily or as prescribed by a physician

  • Do not mix with other drugs in the same IV line

  • Suitable for use in hospital or ICU settings only


Safety Advice:

  • Monitor platelet count, CBC, and renal/liver function during prolonged therapy

  • Watch for signs of lactic acidosis, optic neuropathy, or peripheral neuropathy if used >14 days

  • Avoid use with MAO inhibitors or serotonergic agents due to risk of serotonin syndrome


Precautions:

  • Not recommended for use >28 days without strict monitoring

  • Use caution in patients with hypertension, thyrotoxicosis, or psychiatric disorders

  • Contraindicated in patients with known hypersensitivity to linezolid

  • Store at room temperature (below 25°C); do not freeze

  • Use immediately after opening – single-use container

Reviews

There are no reviews yet.

Be the first to review “LINOZEM® Injection”

Your email address will not be published. Required fields are marked *